M21-471 Ph2b PoC Study (2068-201-008)
ClinicalTrials.gov NCT05216250
Research payments
$119,401
Through program year 2024, $119,401 in research payments was reported against M21-471 Ph2b PoC Study (2068-201-008), across 33 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT05216250
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $119,401 | 33 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Peter McAllister Fairfield, CT Named on 1 payment
- Khashayar Dashtipour Loma Linda, CA Named on 1 payment
- Delaram Safarpour Portland, OR Named on 1 payment
- Nicki Niemann Phoenix, AZ Named on 1 payment
- Michael Soileau Georgetown, TX Named on 1 payment
- Rajesh Pahwa Kansas City, KS Named on 1 payment
- Diana Apetauerova Burlington, MA Named on 1 payment
- Christine Cooper Charleston, SC Named on 1 payment
- Melissa Heiry Philadelphia, PA Named on 1 payment
- Atul Patel Overland Park, KS Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.